Literature DB >> 20661648

C/EBPε participates in all-trans retinoic acid induction of PI3Kγ in U937 cells via an intronic matrix attachment region sequence.

Rong Cai1, Xia Cai, Bin Chen, Weirong Xu, Jian Lu.   

Abstract

ATRA (all-trans retinoic acid) regulates gene expression by binding as a ligand to its specific receptors like C/EBPε which is directly induced. In the U937 cell line, PI3Kγ is selectively induced over other PI3Ks by ATRA, although the mechanism is still unclear. Here, we show that C/EBPε and PI3Kγ are induced in U937 cells by ATRA both in levels of mRNA and protein. Reporter gene assay revealed that C/EBPε is able to interact with a previously identified 2 kb MAR (matrix attachment region) sequence in the last intron of PI3Kγ gene, and increases its linked heterogeneous reporter gene expression. ChIP assay showed that induction of endogenous PI3Kγ is at least partially caused by enhanced, direct C/EBPε binding to a 15 bp sequence at nucleotides 1428-1442 within this MAR sequence, and EMSA analysis confirmed this binding in vitro. The results above collectively show that C/EBPε participates in ATRA induction of PI3Kγ.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661648     DOI: 10.1007/s11033-010-0034-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  33 in total

1.  Flanking nuclear matrix attachment regions synergize with the T cell receptor delta enhancer to promote V(D)J recombination.

Authors:  X P Zhong; J Carabaña; M S Krangel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 2.  Gene expression regulation by retinoic acid.

Authors:  James E Balmer; Rune Blomhoff
Journal:  J Lipid Res       Date:  2002-11       Impact factor: 5.922

3.  Modulation of DNA binding properties of CCAAT/enhancer binding protein epsilon by heterodimer formation and interactions with NFkappaB pathway.

Authors:  Alexey M Chumakov; Agnes Silla; Elizabeth A Williamson; H Phillip Koeffler
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

4.  Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites.

Authors:  P N Cockerill; W T Garrard
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

5.  All-trans retinoic acid-induced expression of bactericidal/permeability-increasing protein (BPI) in human myeloid cells correlates to binding of C/EBPbeta and C/EBPepsilon to the BPI promoter.

Authors:  Andreas Lennartsson; Karina Vidovic; Malene Bjerregaard Pass; Jack B Cowland; Urban Gullberg
Journal:  J Leukoc Biol       Date:  2006-05-09       Impact factor: 4.962

6.  DNase I hypersensitivity analysis of the human CCAAT enhancer binding protein epsilon (C/EBPepsilon) gene.

Authors:  T Kubota; T Hirama; W Verbeek; S Kawano; D Y Chih; A M Chumakov; H Taguchi; H P Koeffler
Journal:  Leuk Res       Date:  2001-11       Impact factor: 3.156

7.  C/EBPepsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters.

Authors:  W Verbeek; A F Gombart; A M Chumakov; C Müller; A D Friedman; H P Koeffler
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

8.  CCAAT/enhancer binding protein epsilon: changes in function upon phosphorylation by p38 MAP kinase.

Authors:  Elizabeth A Williamson; Ian K Williamson; Alexey M Chumakov; Alan D Friedman; H Phillip Koeffler
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

9.  Protein inhibitors of activated STAT resemble scaffold attachment factors and function as interacting nuclear receptor coregulators.

Authors:  Jiann-An Tan; Susan H Hall; Katherine G Hamil; Gail Grossman; Peter Petrusz; Frank S French
Journal:  J Biol Chem       Date:  2002-03-04       Impact factor: 5.157

10.  Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation.

Authors:  Jinyong Kim; Carrie A Cantwell; Peter F Johnson; Curt M Pfarr; Simon C Williams
Journal:  J Biol Chem       Date:  2002-08-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.